Based on this observation, it has been hypothesised that selective NCX blockade may prevent the formation of triggered arrhythmias, and consequently may prevent, reduce, or suppress AF, i.e., it was proposed that NCX blockers can be useful antiarrhythmic drugs [127,128,129]. This evidence concerns the gene TLX2 and cardiac arrhythmia.